Homeopathy Assessment in Terms of the Consumption of Analgesics After Knee Ligamentoplasty
| Tracking Information | |||||
|---|---|---|---|---|---|
| First Received Date ICMJE | September 14, 2005 | ||||
| Last Updated Date | November 9, 2006 | ||||
| Start Date ICMJE | December 2003 | ||||
| Primary Completion Date | Not Provided | ||||
| Current Primary Outcome Measures ICMJE |
Morphine consumption delivered by PCA between 0 and 24 hours after a knee ligamentoplasty | ||||
| Original Primary Outcome Measures ICMJE | Same as current | ||||
| Change History | Complete list of historical versions of study NCT00222365 on ClinicalTrials.gov Archive Site | ||||
| Current Secondary Outcome Measures ICMJE |
|
||||
| Original Secondary Outcome Measures ICMJE |
|
||||
| Current Other Outcome Measures ICMJE | Not Provided | ||||
| Original Other Outcome Measures ICMJE | Not Provided | ||||
| Descriptive Information | |||||
| Brief Title ICMJE | Homeopathy Assessment in Terms of the Consumption of Analgesics After Knee Ligamentoplasty | ||||
| Official Title ICMJE | Homeopathy Assessment in Terms of the Consumption of Analgesics After Knee Ligamentoplasty | ||||
| Brief Summary | This is an add-on, double blind, and randomised clinical trial with three groups: a homeopathic group, a placebo group, and a temporal control group. The aim of this trial is to assess the effect of homeopathy on the consumption of morphine delivered by PCA (patient control analgesia) for 24 hours after a knee ligamentoplasty. |
||||
| Detailed Description | We test the effectiveness of an homeopathic drug versus placebo and a temporal control group (patient with no add-on treatment) following orthopedic knee surgery. All patients have a PCA of morphine for 24 hours after surgery. After this period they can take an oral tablet of morphine on request. Group A: Patients with study treatment (homeopathy) allocation. Double blind group with 70 patients Group B: Patients with placebo allocation. Double blind group with 70 patients Group C: Temporal control group with patients who take only the morphine. Open group with 25 patients The total power: 70 +70 + 25 = 165 patients Main Objective:
Secondary Objectives:
Main Assessment Criterion:
Secondary Assessment Criteria:
Inclusion Criteria:
Exclusion Criteria:
|
||||
| Study Type ICMJE | Interventional | ||||
| Study Phase | Phase 3 | ||||
| Study Design ICMJE | Allocation: Randomized Endpoint Classification: Efficacy Study Intervention Model: Parallel Assignment Masking: Double-Blind Primary Purpose: Treatment |
||||
| Condition ICMJE | Pain | ||||
| Intervention ICMJE |
|
||||
| Study Arm (s) | Not Provided | ||||
| Publications * |
|
||||
|
* Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline. |
|||||
| Recruitment Information | |||||
| Recruitment Status ICMJE | Terminated | ||||
| Enrollment ICMJE | 165 | ||||
| Completion Date | May 2006 | ||||
| Primary Completion Date | Not Provided | ||||
| Eligibility Criteria ICMJE | Inclusion Criteria:
Exclusion Criteria:
|
||||
| Gender | Both | ||||
| Ages | 18 Years to 60 Years | ||||
| Accepts Healthy Volunteers | No | ||||
| Contacts ICMJE | Contact information is only displayed when the study is recruiting subjects | ||||
| Location Countries ICMJE | France | ||||
| Administrative Information | |||||
| NCT Number ICMJE | NCT00222365 | ||||
| Other Study ID Numbers ICMJE | DCIC 03 10 | ||||
| Has Data Monitoring Committee | Not Provided | ||||
| Responsible Party | Not Provided | ||||
| Study Sponsor ICMJE | University Hospital, Grenoble | ||||
| Collaborators ICMJE | Not Provided | ||||
| Investigators ICMJE |
|
||||
| Information Provided By | University Hospital, Grenoble | ||||
| Verification Date | July 2006 | ||||
|
ICMJE Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP |
|||||